Exact Sciences PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
Exact Sciences (EXAS) reported Q3 EPS of ($0.84), $0.23 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $523.1 million versus the consensus estimate...
Genome sequencing solutions company Illumina (NASDAQ:ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused shares to spiral down...
Cost of sequencing a single human genome has fallen from $100 million to $600 since 2001 Illumina’s new machines can further drop the cost to under $200 Illumina won an...
Cathie Wood announced the upcoming closure of the ARK Transparency ETF Despite declines, investors continue to follow Wood’s holdings closely Consider 2 Ark Invest ETFs that...
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company’s pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
| Average | 60.65 (+42.20% Upside) |
| High | 95 |
| Low | 35 |
| Price | 42.65 |
| No. of Analysts | 17 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Buy | Buy | Sell |
| Technical Indicators | Strong Sell | Sell | Strong Buy | Buy | Strong Sell |
| Summary | Strong Sell | Sell | Strong Buy | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 148.11 | 148.88 | 147.12 | -2.96 | -1.96% | 35.17M | NASDAQ | |||
| 3.41 | 3.425 | 3.385 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 40.46 | 40.47 | 39.81 | +0.35 | +0.87% | 4.62M | NYSE | |||
| 81.40 | 82.37 | 81.40 | -0.57 | -0.70% | 5.91M | NYSE | |||
| 93.41 | 94.43 | 93.07 | -0.72 | -0.76% | 35.07M | NASDAQ | |||
| 102.49 | 103.48 | 101.87 | +0.41 | +0.40% | 1.45M | NASDAQ | |||
| 111.41 | 112.73 | 111.02 | -0.83 | -0.74% | 12.00M | NASDAQ | |||
| 533.66 | 535.86 | 533.07 | -0.83 | -0.16% | 744.15K | NASDAQ | |||
| 135.03 | 135.03 | 134.00 | +1.03 | +0.77% | 540.49K | NYSE | |||
| 136.74 | 137.14 | 136.05 | +0.26 | +0.19% | 3.22M | NYSE | |||
| 7.51 | 7.74 | 7.50 | -0.13 | -1.70% | 8.29M | NYSE | |||
| 62.69 | 62.81 | 62.38 | +0.06 | +0.10% | 5.17M | NYSE | |||
| 86.26 | 86.41 | 84.76 | +0.84 | +0.98% | 4.03M | NASDAQ | |||
| 162.70 | 164.87 | 161.72 | -2.49 | -1.51% | 16.79M | NASDAQ | |||
| 28.02 | 28.12 | 27.83 | +0.21 | +0.76% | 31.91K | NASDAQ |